Text Size A A A

Sun Pharma In The News

Tell a Friend Print Home » Media » Sun Pharma In The News

Sun gets US nod for anti-anxiety drug


Sun Pharmaceutical Industries Ltd, India's largest drug maker by value, on Friday said it has received marketing approval from the US Food and Drug Administration (FDA) for its generic version of Pfizer Inc.'s anxiety disorder drug Xanax.
This drug, known as alprazolam in generic terms, has total annual sales of $145 million (Rs670 crore) in the US, and is prescribed for panic disorders, with or without agoraphobia, which is a fear of public places that is sometimes induced by the fear of having a panic attack in such places